Dr. Bo Xu serves as distinguished fellow and chair of oncology in Southern Research’s Oncology Department. In this role, he oversees cancer research and oncology drug discovery in the drug discovery division. He is also the co-principal investigator of the NCI-designated Chemical Biology Consortium Comprehensive Center at SR. He is Professor of pathology and cell biology at the University of Alabama at Birmingham (UAB), a training faculty at the UAB Graduate Medical Sciences, and a member (senior scientist) at the NCI-designated Comprehensive Cancer Center at UAB. Continuously funded by the NIH and other federal/local/private organizations, Xu’s main research interests are mechanisms of the DNA damage response and cancer drug discovery.
Xu graduated from the Norman Bethune University of Medical Sciences with a medical degree and obtained a doctorate degree in radiation oncology from Peking Union Medical College in 1998. He completed his postdoctoral training at St. Jude Children’s Research Hospital in Memphis, Tennessee. In 2002, Dr. Xu started his independent research at the LSU Health Sciences Center New Orleans as a tenure-track assistant professor in the Department of Genetics. He joined Southern Research in 2006, serving as the head of the Molecular Radiobiology Laboratory. Between 2009 and 2012, he served as senior member and director of the Molecular Radiation Oncology Laboratory in The Methodist Hospital Research Institute, Weill Cornell Medical College.